IP Library Granted Patent US 10,835,642
Granted Patent B2
US 10,835,642 · App. 16/047,420 · Granted Nov 17, 2020

Moldable bone graft compositions

Inventors: John E. Brunelle (Huntington Beach, CA); Russell L. Cook (Newport Beach, CA); Duraid S. Antone (Laguna Nigel, CA)
Assignee: Bioventus, LLC
A61L27/58A61L27/46A61L27/50A61L27/54A61L2300/404A61L2400/06A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,835,642
App. No.
16/047,420
Granted
Nov 17, 2020
Kind
B2
Abstract

The present disclosure relates to compositions useful in synthetic bone graft applications. Particularly, the disclosure teaches moldable bone graft compositions, methods of making said compositions, and methods of utilizing the same.

Claims (28)

1. A moldable bone graft composition, comprising:

a) one or more bioresorbable polymers;

b) biphasic calcium phosphate particles comprising hydroxyapatite and tricalcium phosphate; and

c) a bioactive glass component,

wherein said biphasic calcium phosphate particles and said bioactive glass together comprise about 20-60% by weight of the moldable bone graft composition.

2. The moldable bone graft composition of claim 1 , wherein the bioactive glass component comprises about 1-40% by weight of the moldable bone graft composition.

3. The moldable bone graft composition of claim 1 , wherein the one or more bioresorbable polymers comprise a polyalkylene oxide polymer having at least one of the following: a molecular weight of about 500-1500 grams/mole; a specific gravity of about 1.0-1.3 (at 25° C.); a viscosity of about 10-40 cSt (at 210° C.); or a melting temperature of about 38-50° C.

4. The moldable bone graft composition of claim 1 , wherein the biphasic calcium phosphate particles comprise about 20-60% hydroxyapatite and about 40-80% tricalcium phosphate.

5. The moldable bone graft composition of claim 1 , wherein the biphasic calcium phosphate particles have interconnected macro- and microporosity.

6. The moldable bone graft composition of claim 1 , wherein about 30-90% of the biphasic calcium phosphate particles have a particle size of about 1000-2000 μm; about 10-70% of the biphasic calcium phosphate particles have a particle size of about 425-1000 μm, about 10-50% of the biphasic calcium phosphate particles have a particle size of about 710-1000 μm; and about 1-30% of the biphasic calcium phosphate particles have a particle size of about 425-710 μm.

7. The moldable bone graft composition of claim 1 , wherein at least 80% of the bioactive glass is in the form of particles having a particle size of about 212-425 μm.

8. The moldable bone graft composition of claim 1 , wherein the bioactive glass is in the form of irregular granules, approximately spherical particles, or fibers.

9. The moldable bone graft composition of claim 1 , wherein about 60-90% of the biphasic calcium phosphate particles and bioactive glass together are in the form of particles having a particle size of about 425-2000 μm, and about 10-40% of the particles have a particle size of about 1-425 μm.

10. The moldable bone graft composition of claim 1 , further comprising: a melt skin layer disposed on the outer surface of the composition, wherein the melt skin layer comprises the bioresorbable polymer.

11. A moldable bone graft composition, comprising:

a) about 30-90% by weight of one or more bioresorbable polymers;

b) about 2-62% by weight of biphasic calcium phosphate particles comprising hydroxyapatite and tricalcium phosphate; and

c) a bioactive glass component,

wherein said biphasic calcium phosphate particles and said bioactive glass together comprise at least about 10-70% by weight of the moldable bone graft composition.

12. The moldable bone graft composition of claim 11 , wherein the bioactive glass component comprises about 1-40% by weight of the moldable bone graft composition.

13. The moldable bone graft composition of claim 11 , wherein the one or more bioresorbable polymers comprise a polyalkylene oxide polymer having at least one of the following: a molecular weight of about 500-1500 grams/mole; a specific gravity of about 1.0-1.3 (at 25° C.); a viscosity of about 10-40 cSt (at 210° C.); or a melting temperature of about 38-50° C.

14. The moldable bone graft composition of claim 11 , wherein the biphasic calcium phosphate particles comprise about 20-60% hydroxyapatite and about 40-80% tricalcium phosphate.

15. The moldable bone graft composition of claim 11 , wherein the biphasic calcium phosphate particles have interconnected macro- and microporosity.

16. The moldable bone graft composition of claim 11 , wherein about 30-90% of the biphasic calcium phosphate particles have a particle size of about 1000-2000 μm; about 10-70% of the biphasic calcium phosphate particles have a particle size of about 425-1000 μm, about 10-50% of the biphasic calcium phosphate particles have a particle size of about 710-1000 μm; and about 1-30% of the biphasic calcium phosphate particles have a particle size of about 425-710 μm.

17. The moldable bone graft composition of claim 11 , wherein at least 80% of the bioactive glass is in the form of particles having a particle size of about 212-425 μm.

18. The moldable bone graft composition of claim 11 , wherein the bioactive glass is in the form of irregular granules, approximately spherical particles, or fibers.

19. The moldable bone graft composition of claim 11 , wherein about 60-90% of the biphasic calcium phosphate particles and bioactive glass together are in the form of particles having a particle size of about 425-2000 μm, and about 10-40% of the particles have a particle size of about 1-425 μm.

20. The moldable bone graft composition of claim 11 , further comprising: a melt skin layer disposed on the outer surface of the composition, wherein the melt skin layer comprises the bioresorbable polymer.

Assignments (5)
SECURITY INTEREST Recorded Aug 1, 2025
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 071904/0465 →
RELEASE OF SECURITY INTEREST Recorded Aug 1, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 071909/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2020
From: BRUNELLE, JOHN E.; COOK, RUSSELL L.; ANTONE, DURAID S.
To: BIOSTRUCTURES, LLC.
Reel/Frame 051580/0500 →
MERGER AND CHANGE OF NAME Recorded Jan 22, 2020
From: BIOSTRUCTURES, LLC.; BIOVENTUS LLC
To: BIOVENTUS LLC
Reel/Frame 051580/0528 →
SECURITY INTEREST Recorded Dec 13, 2019
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 051272/0143 →
Continuity (4)
Continuation 15395301 · Dec 30, 2016
Continuation 14939902 · Nov 12, 2015
Provisional Application 62079047 · Nov 13, 2014
Related Publication 20190167853A1 · Jun 6, 2019